UBS Group’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $11.7M | Sell |
|
|||||
|
2025
Q2 | $18.3M | Buy |
|
|||||
|
2025
Q1 | $18.4M | Buy |
|
|||||
|
2024
Q4 | $15.1M | Buy |
|
|||||
|
2024
Q3 | $4.23M | Buy |
|
|||||
|
2024
Q2 | $2.62M | Sell |
|
|||||
|
2024
Q1 | $6.2M | Sell |
|
|||||
|
2023
Q4 | $7.89M | Buy |
|
|||||
|
2023
Q3 | $3.98M | Sell |
|
|||||
|
2023
Q2 | $4.81M | Sell |
|
|||||
|
2023
Q1 | $6.43M | Sell |
|
|||||
|
2022
Q4 | $11M | Buy |
|
|||||
|
2022
Q3 | $4.22M | Buy |
|
|||||
|
2022
Q2 | $2.28M | Buy |
|
|||||
|
2022
Q1 | $2.61M | Buy |
|
|||||
|
2021
Q4 | $1.96M | Sell |
|
|||||
|
2021
Q3 | $2.35M | Buy |
|
|||||
|
2021
Q2 | $2.28M | Sell |
|
|||||
|
2021
Q1 | $2.58M | Buy |
|
|||||
|
2020
Q4 | $1.1M | Buy |
|
|||||
|
2020
Q3 | $819K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $9K | Sell |
|
|||||
|
2019
Q4 | $68K | Sell |
|
|||||
|
2019
Q3 | $1.2M | Buy |
|
|||||
|
2019
Q2 | $85K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $69K | Buy |
|
|||||
|
2018
Q3 | $88K | Buy |
|
|||||
|
2018
Q2 | $38K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $42K | Buy |
|
|||||
|
2017
Q3 | $6K | Sell |
|
|||||
|
2017
Q2 | $17K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $38K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $13K | Buy |
|
|||||
|
2015
Q1 | – | Hold |
|
|||||
|
2014
Q4 | – | Hold |
|